Roivant Sciences Ltd. Dividend History (ROIV)

About Roivant Sciences Ltd.

Roivant Sciences Ltd. is a biopharmaceutical company headquartered in Basel, Switzerland, and was founded in 2014 by Vivek Ramaswamy. Roivant stands out for its innovative business model focused on efficiently developing a diverse range of novel therapeutics through subsidiary companies known as "Vants." Each of these subsidiaries concentrates on specific therapeutic areas or technologies, enabling targeted and accelerated drug development. As of 2023, the CEO of Roivant Sciences is Matt Gline. The company has experienced significant growth and has formed numerous partnerships and collaborations to enhance its research and development capabilities. In 2023, Roivant reported substantial revenue, reflecting success in advancing several promising clinical programs. The company is well-regarded for its focus on addressing unmet medical needs and leveraging technology to streamline the drug development process.